Iberdrola Expands its Alliance With Pharmaceutical Giant Bayer to Supply Green Energy in Italy

Iberdrola and German pharmaceutical giant Bayer have extended their partnership, signing a green power purchase agreement (PPA) in Italy for 11 years from January 2025, for a total of 33 GWh over the period.

The agreement expands the international alliance between Bayer and Iberdrola, adding to existing agreements between the two companies in Spain and Mexico to promote cleaner and more sustainable consumption. Bayer's plant in Garbagnate (Milan) will use only electricity from renewable sources, confirming the pharmaceutical company's commitment to environmental sustainability.

The energy will be produced by the Montefiascone photovoltaic plant (in the Lazio region), Iberdrola's second photovoltaic plant in Italy with a total installed capacity of 7 MW. Once operational, the plant will prevent the emission into the atmosphere of more than 3,200 tonnes of CO2, equivalent to the electricity demand of more than 4,000 homes.

Iberdrola's role in Italy
Iberdrola is actively involved in the development of strategies and solutions for industrial decarbonisation, based on the use of renewables and the promotion of self-consumption, which enable the reduction of environmental impact.

With the inauguration of its second operational plant and the completion of the photovoltaic plants already authorised, Iberdrola will have an operational capacity of 400 MW in Italy by 2025.

Several companies in Italy have already entrusted Iberdrola with the long-term supply of green energy through corporate PPA agreements, such as those signed this year with the Tosano supermarket chain and the BTicino metallurgical company.